Prevalence of low bone mass and changes in vitamin D levels in human immunodeficiency virus-infected adults unexposed to antiretrovirals

Abstract INTRODUCTION: The prevalence of low bone mass is 3 times higher in people living with human immunodeficiency virus (PLWH) and using antiretrovirals than in the HIV-unaffected population. Changes in vitamin D levels is one of the factors associated with decreased bone mass. The objective o...

Full description

Bibliographic Details
Main Authors: Nathalia Sernizon Guimarães, Milena Maria Moreira Guimarães, Adriana Maria Kakehasi, Mariana Guimarães Penido de Paula, Júlia Fonseca de Morais Caporali, Érica Leandro Marciano Vieira, Pedro Rezende Tanajura, Unaí Tupinambás
Format: Article
Language:English
Published: Sociedade Brasileira de Medicina Tropical (SBMT)
Series:Revista da Sociedade Brasileira de Medicina Tropical
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822018000500596&lng=en&tlng=en
_version_ 1828732230392872960
author Nathalia Sernizon Guimarães
Milena Maria Moreira Guimarães
Adriana Maria Kakehasi
Mariana Guimarães Penido de Paula
Júlia Fonseca de Morais Caporali
Érica Leandro Marciano Vieira
Pedro Rezende Tanajura
Unaí Tupinambás
author_facet Nathalia Sernizon Guimarães
Milena Maria Moreira Guimarães
Adriana Maria Kakehasi
Mariana Guimarães Penido de Paula
Júlia Fonseca de Morais Caporali
Érica Leandro Marciano Vieira
Pedro Rezende Tanajura
Unaí Tupinambás
author_sort Nathalia Sernizon Guimarães
collection DOAJ
description Abstract INTRODUCTION: The prevalence of low bone mass is 3 times higher in people living with human immunodeficiency virus (PLWH) and using antiretrovirals than in the HIV-unaffected population. Changes in vitamin D levels is one of the factors associated with decreased bone mass. The objective of this study is to evaluate the low bone mass and altered vitamin D levels in PLWH who have not been exposed to antiretrovirals. METHODS: A cross-sectional study was carried out with HIV-infected individuals between the ages of 18 and 55 years immediately prior to the start of antiretroviral therapy in a specialized reference center focusing on infectious and parasitic diseases. Results of clinical examination (patient’s weight, height, blood pressure, and clinical history), laboratory tests, and X-ray absorptiometry, were collected. RESULTS: Sixty patients were included, with a mean age of 34 years. Nine (16.7%) patients presented with low bone mass and 4 (7.1%) patients showed low total femur BMD. Analysis revealed that 23.3% and 36.7% of the patients had deficient and insufficient levels of 25-hydroxyvitamin D3, respectively. CONCLUSIONS: Our study population presented with compromised bone health and with low bone mineral density and 25-(OH)-vitamin D levels.
first_indexed 2024-04-12T17:58:01Z
format Article
id doaj.art-f62916e58b31488faad39a4bf820417c
institution Directory Open Access Journal
issn 1678-9849
language English
last_indexed 2024-04-12T17:58:01Z
publisher Sociedade Brasileira de Medicina Tropical (SBMT)
record_format Article
series Revista da Sociedade Brasileira de Medicina Tropical
spelling doaj.art-f62916e58b31488faad39a4bf820417c2022-12-22T03:22:16ZengSociedade Brasileira de Medicina Tropical (SBMT)Revista da Sociedade Brasileira de Medicina Tropical1678-984951559660210.1590/0037-8682-0475-2017S0037-86822018000500596Prevalence of low bone mass and changes in vitamin D levels in human immunodeficiency virus-infected adults unexposed to antiretroviralsNathalia Sernizon GuimarãesMilena Maria Moreira GuimarãesAdriana Maria KakehasiMariana Guimarães Penido de PaulaJúlia Fonseca de Morais CaporaliÉrica Leandro Marciano VieiraPedro Rezende TanajuraUnaí TupinambásAbstract INTRODUCTION: The prevalence of low bone mass is 3 times higher in people living with human immunodeficiency virus (PLWH) and using antiretrovirals than in the HIV-unaffected population. Changes in vitamin D levels is one of the factors associated with decreased bone mass. The objective of this study is to evaluate the low bone mass and altered vitamin D levels in PLWH who have not been exposed to antiretrovirals. METHODS: A cross-sectional study was carried out with HIV-infected individuals between the ages of 18 and 55 years immediately prior to the start of antiretroviral therapy in a specialized reference center focusing on infectious and parasitic diseases. Results of clinical examination (patient’s weight, height, blood pressure, and clinical history), laboratory tests, and X-ray absorptiometry, were collected. RESULTS: Sixty patients were included, with a mean age of 34 years. Nine (16.7%) patients presented with low bone mass and 4 (7.1%) patients showed low total femur BMD. Analysis revealed that 23.3% and 36.7% of the patients had deficient and insufficient levels of 25-hydroxyvitamin D3, respectively. CONCLUSIONS: Our study population presented with compromised bone health and with low bone mineral density and 25-(OH)-vitamin D levels.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822018000500596&lng=en&tlng=enBone massVitamin DHIVPeople living with HIVBiomarker
spellingShingle Nathalia Sernizon Guimarães
Milena Maria Moreira Guimarães
Adriana Maria Kakehasi
Mariana Guimarães Penido de Paula
Júlia Fonseca de Morais Caporali
Érica Leandro Marciano Vieira
Pedro Rezende Tanajura
Unaí Tupinambás
Prevalence of low bone mass and changes in vitamin D levels in human immunodeficiency virus-infected adults unexposed to antiretrovirals
Revista da Sociedade Brasileira de Medicina Tropical
Bone mass
Vitamin D
HIV
People living with HIV
Biomarker
title Prevalence of low bone mass and changes in vitamin D levels in human immunodeficiency virus-infected adults unexposed to antiretrovirals
title_full Prevalence of low bone mass and changes in vitamin D levels in human immunodeficiency virus-infected adults unexposed to antiretrovirals
title_fullStr Prevalence of low bone mass and changes in vitamin D levels in human immunodeficiency virus-infected adults unexposed to antiretrovirals
title_full_unstemmed Prevalence of low bone mass and changes in vitamin D levels in human immunodeficiency virus-infected adults unexposed to antiretrovirals
title_short Prevalence of low bone mass and changes in vitamin D levels in human immunodeficiency virus-infected adults unexposed to antiretrovirals
title_sort prevalence of low bone mass and changes in vitamin d levels in human immunodeficiency virus infected adults unexposed to antiretrovirals
topic Bone mass
Vitamin D
HIV
People living with HIV
Biomarker
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822018000500596&lng=en&tlng=en
work_keys_str_mv AT nathaliasernizonguimaraes prevalenceoflowbonemassandchangesinvitamindlevelsinhumanimmunodeficiencyvirusinfectedadultsunexposedtoantiretrovirals
AT milenamariamoreiraguimaraes prevalenceoflowbonemassandchangesinvitamindlevelsinhumanimmunodeficiencyvirusinfectedadultsunexposedtoantiretrovirals
AT adrianamariakakehasi prevalenceoflowbonemassandchangesinvitamindlevelsinhumanimmunodeficiencyvirusinfectedadultsunexposedtoantiretrovirals
AT marianaguimaraespenidodepaula prevalenceoflowbonemassandchangesinvitamindlevelsinhumanimmunodeficiencyvirusinfectedadultsunexposedtoantiretrovirals
AT juliafonsecademoraiscaporali prevalenceoflowbonemassandchangesinvitamindlevelsinhumanimmunodeficiencyvirusinfectedadultsunexposedtoantiretrovirals
AT ericaleandromarcianovieira prevalenceoflowbonemassandchangesinvitamindlevelsinhumanimmunodeficiencyvirusinfectedadultsunexposedtoantiretrovirals
AT pedrorezendetanajura prevalenceoflowbonemassandchangesinvitamindlevelsinhumanimmunodeficiencyvirusinfectedadultsunexposedtoantiretrovirals
AT unaitupinambas prevalenceoflowbonemassandchangesinvitamindlevelsinhumanimmunodeficiencyvirusinfectedadultsunexposedtoantiretrovirals